2024-05-07 10:05:19 ET
Esperion Therapeutics, Inc. (ESPR)
Q1 2024 Earnings Conference Call
May 07, 2024 08:00 AM ET
Company Participants
Tiffany Aldrich - Associate Director, Corporate Communications
Sheldon Koenig - President & Chief Executive Officer
Ben Halladay - Chief Financial Officer
Eric Warren - Chief Commercial Officer
JoAnne Foody - Chief Medical Officer
Conference Call Participants
Dennis Ding - Jefferies
Serge Belanger - Needham
Tom Shrader - BTIG
Jessica Fye - JPMorgan
Joe Pantginis - H.C. Wainwright
Jason Zemansky - Bank of America
Presentation
Operator
Ladies and gentlemen, thank you for standing by and welcome. At this time, all participants are in a listen-only mode. Following the presentation, there will be a question-and-answer session. Please be advised that today's conference call may be recorded.
I would now like to hand the conference over to Tiffany Aldrich, Associate Director of Corporate Communications at Esperion. Please go ahead.
Tiffany Aldrich
Thank you, operator. Good morning and welcome to Esperion's first quarter 2024 earnings conference call. With us today are Sheldon Koenig, President and CEO; and Ben Halladay, CFO. Other members of the executive team will be available for Q&A following our prepared remarks.
We issued a press release earlier this morning detailing the content of today's call. A copy of that release can be found on the Investor page of our website together with a copy of the presentation that we will also be referencing....
Read the full article on Seeking Alpha
For further details see:
Esperion Therapeutics, Inc. (ESPR) Q1 2024 Earnings Call Transcript